Browsing by Author "Silva, Marcelo."
Now showing items 1-14 of 14
-
Comment on "Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation"
Piñero, Federico.; Rubinstein, Fernando.; Silva, Marcelo.; Et al. (2021-12) -
Developing multicenter consortia in liver disease in Latin America: Challenges and opportunities.
Mendizabal, Manuel.; Silva, Marcelo. (Wiley, 2017-06-07)The development of consortia has been useful for exploring challenging scenarios and uncharted territories in liver disease treatments. Several consortia already developed in the United States and Europe have become key ... -
Direct-acting antiviral treatment failure in genotype 2 hepatitis C chronic infection
Piñero, Federico.; Mendizabal, Manuel.; Silva, Marcelo.; Et al. (Wiley, 2021-02)Comment J Viral Hepat . 2021 Feb;28(2):446-447. doi: 10.1111/jvh.13433. Epub 2020 Nov 18. Direct-acting antiviral treatment failure in genotype 2 hepatitis C chronic infection Ezequiel Ridruejo 1 2 3, Federico Piñero 2 ... -
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
Piñero, Federico.; Silva, Marcelo. (Wiley, 2017-10-01)We have read with interest the article recently pub-lished by Zanetto et al. inLiver Transplantationregarding the effect on radiologic progression of hepa-tocellular carcinoma (HCC) after the treatment withdirect-acting ... -
Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver
Mendizabal, Manuel.; Silva, Marcelo.; Bessone, Fernando.; Et al. (Elsevier, 2021-09)Abstract Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, ... -
Hepatitis C virus infection in Argentina: Burden of chronic disease.
Ridruejo, Ezequiel.; Bessone, Fernando.; Daruich, Jorge.; Estes, Chris.; Gadano, Adrián.; Razavi, Homie.; Villamil, Federico.; Silva, Marcelo. (Baishideng Publishing Group, 2016-05-28)AIM: To estimate the progression of the hepatitis C virus (HCV) epidemic and measure the burden of HCV-related morbidity and mortality. METHODS: Age- and gender-defined cohorts were used to follow the viremic population ... -
Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
Piñero, Federico.; Poniachk, Jaime.; Ridruejo, Ezequiel.; Silva, Marcelo. (Baishideng Publishing Group, 2018-10-07)Abstract Latin America, a region with a population greater than 600000000 individuals, is well known due to its wide geographic, socio-cultural and economic heterogeneity. Access to health care remains as the main barrier ... -
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.
Silva, Marcelo.; Arab, Juan Pablo.; Dirchwolf, Melisa.; Et al. (Elsevier, 2020-11)Abstract Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its ... -
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
Mendizabal, Manuel.; Silva, Marcelo.; Efe, Cumali.; Et al. (Lippincott, Williams & Wilkins, 2021-06)Abstract Background and aims: Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking. Approach and results: We performed a retrospective study on patients with AIH and COVID-19 from ... -
Predictive models for recurrence risk of hepatocellular carcinoma after liver transplantation: Still an unmet need.
Piñero, Federico.; Carrihlo, Flair.; Silva, Marcelo. (Wiley, 2017-05-01)Recurrence of hepatocellular carcinoma (HCC) after liver transplanta-tion (LT) is a frightening issue. It is considered a systemic advanced stage with poor survival rate from the time of its diagnosis, with few therapeutic ... -
'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant
Mendizabal, Manuel.; Silva, Marcelo.; Fabrizi, Fabrizio.; Et al. (Elsevier, 2021-11)Abstract Introductions and objectives: The introduction of direct-acting antiviral (DAA) agents promises to change dramatically the management of hepatitis C in kidney transplant recipients, a patient group where the ... -
Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort
Silva, Marcelo.; Piñero, Federico.; Maccali, Claudia.; Et al. (Wiley, 2021-04)Abstract Background & aim: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) has a poor prognosis, and the adjusted effect of different treatments on post-recurrence survival (PRS) has not been ... -
Simplified treatment of hepatitis C: another strategy to overcome the barriers to its elimination
Mendizabal, Manuel.; Silva, Marcelo.; Ridruejo, Ezequiel. (Medicina Buenos Aires, 2021-01)Abstract in English, Spanish The clinical management of hepatitis C virus (HCV) infection presents several challenges today. WHO's goal is to eliminate it by 2030. It is an ambitious goal and difficult to meet given the ... -
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
Silva, Marcelo.; Arrese, Marco.; Mendez-Sanchez, Nahum.; Et al. (Elsevier, 2021-01)Abstract The Latin American Association for the Study of the Liver (Asociación Latinoamericana para el Estudio del Hígado; ALEH) represents liver professionals in Latin America with the mission of promoting liver health ...